Multiple high dose chemotherapy with peripheral blood stem cells (PBSC) reinfusion in high risk breast cancer

被引：0
|
作者：
Cocorocchio, E [1 ]
Peccatori, F [1 ]
Zimatore, M [1 ]
Ferrucci, PF [1 ]
Cinieri, S [1 ]
Agazzi, A [1 ]
Martinelli, G [1 ]
机构：
[1] European Inst Oncol, Div Med Oncol, Milan, Italy
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
43P
引用
收藏
页码：9 / 9
页数：1
相关论文
共 50 条
  • [1] Secondary leukemia (sL) after multiple high-dose chemotherapy (HDCT) with peripheral blood stem cells (PBSC) reinfusion for high risk breast cancer (HRBC) patients (pts)
    Cinieri, S
    Cocorocchio, E
    Ferrucci, PF
    Peccatori, FA
    Rabascio, C
    Alietti, A
    Laszlo, D
    Giordano, G
    Agazzi, A
    Pastano, R
    Vanazzi, A
    Bertolini, F
    Pruneri, G
    Goldhirsch, A
    Martinelli, G
    [J]. BLOOD, 2003, 102 (11) : 979A - 979A
  • [2] Phase I study of high-dose chemotherapy with peripheral blood stem-cells reinfusion (PBSC) in patients with metastatic or inflammatory breast cancer (MBC).
    Fabbro, M
    Thezenas, S
    Wandzel, S
    Kramar, A
    Martinez, A
    Mir, D
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 63S - 63S
  • [3] High-dose chemotherapy (HDC) with peripheral blood stem cells (PBSC) in the treatment of inflammatory breast cancer (IBC)
    Aieta, M.
    D'Addetta, C.
    Latiano, T. P.
    Palomba, G.
    Maiello, E.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : VII142 - VII142
  • [4] Multiple high-dose chemotherapy with peripheral blood stem cells in high risk breast cancer patients is safe and feasible.
    Cinieri, S
    Ferrucci, PF
    Cocorocchlo, E
    Peccatori, F
    El Taani, H
    Zimatore, M
    Martinelli, G
    [J]. BONE MARROW TRANSPLANTATION, 1999, 23 : S38 - S38
  • [5] Phase II study of leridistim in breast cancer patients following high dose chemotherapy (HDCT) and autologous peripheral blood stem cell (PBSC) reinfusion.
    Weinberger, B
    Reece, D
    Schuster, M
    Herzig, R
    Jansen, J
    Lynch, J
    Miller, A
    Tutschka, P
    Needle, MN
    Baum, CM
    [J]. BLOOD, 1999, 94 (10) : 49A - 49A
  • [6] High dose chemotherapy followed by reinfusion of immunomagnetic purged peripheral blood precursor cells in metastatic and high risk breast cancer patients.
    Musso, M
    Porretto, F
    Crescimanno, A
    Polizzi, V
    Bondi, F
    Scalone, R
    Cajozzo, A
    Mariani, G
    [J]. BONE MARROW TRANSPLANTATION, 1998, 21 : S61 - S61
  • [7] Twin isolations after high dose chemotherapy and peripheral blood stem cell (PBSC) transplantation for high risk breast cancer: Psychological and microbiological assessment.
    Cocquio, A
    Roberta, M
    Ilaria, M
    Antonella, D
    Compare, L
    Orlando, L
    Rossetti, F
    Casellato, L
    Cocorocchio, E
    Peccatori, F
    Martinelli, G
    [J]. BONE MARROW TRANSPLANTATION, 1998, 21 : S246 - S246
  • [8] Sequential high-dose chemotherapy with peripheral blood stem cell (PBSC) support as adjuvant therapy for patients with high-risk breast cancer.
    Hohaus, S
    Wallwiener, D
    Schneeweiss, A
    Egerer, G
    Martin, S
    Abdallah, A
    Goldschmidt, H
    Fersis, N
    Bastert, G
    Haas, R
    [J]. BONE MARROW TRANSPLANTATION, 1998, 22 : S93 - S94
  • [9] High-dose chemotherapy with peripheral blood stem cell support for high risk breast cancer.
    Schmid, M
    Bauernhofer, T
    Resel, M
    Ploner, F
    Schippinger, W
    Gilli, R
    Lanzer, G
    Truschnig-Wilders, M
    Samonigg, H
    [J]. BONE MARROW TRANSPLANTATION, 1999, 23 : S42 - S42
  • [10] Double high-dose chemotherapy (HDCT) with peripheral blood stem cell transplantation (PBSC) in patients with metastatic breast cancer and high grade lymphoma
    Bojko, P
    Kloster, G
    Weidmann, B
    Gaczkowski, A
    Halbe, J
    Niederle, N
    [J]. BLOOD, 1995, 86 (10) : 3739 - 3739
12345